Foresite Capital Opportunity Management V, LLC - 05 Apr 2023 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role: 10%+ Owner
Signature: /s/ Dennis Ryan, on behalf of Foresite Capital Opportunity Management V, LLC
Issuer symbol: N/A
Transactions as of: 05 Apr 2023
Net transactions value: +$1,160,928
Form type: 4
Filing time: 06 Apr 2023, 21:08:36 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRDS	Common Stock	Purchase	$1,160,928	+773,952	+9.7%	$1.50	8,773,134	05 Apr 2023	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 5, 2023, Foresite Capital Opportunity Fund V, L.P. ("Capital Opportunity Fund V L.P.") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Opportunity Management V, LLC ("FCOMVLLC") is the general partner of Capital Opportunity Fund V L.P. Each of FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

Content

On April 5, 2023, Foresite Capital Opportunity Fund V, L.P. ("Capital Opportunity Fund V L.P.") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Opportunity Management V, LLC ("FCOMVLLC") is the general partner of Capital Opportunity Fund V L.P. Each of FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.